RT Book, Section
A1 Beitler, Jonathan J.
A1 Wadsworth, J. Trad
A1 Saba, Nabil F.
A1 Shin, Dong M.
A1 Hudgins, Patricia A.
A2 Morita, Shane Y.
A2 Balch, Charles M.
A2 Klimberg, V. Suzanne
A2 Pawlik, Timothy M.
A2 Posner, Mitchell C.
A2 Tanabe, Kenneth K.
SR Print(0)
ID 1145758860
T1 Cancer of the Larynx and Hypopharynx
T2 Textbook of Complex General Surgical Oncology
YR 2018
FD 2018
PB McGraw-Hill Education
PP New York, NY
SN 9780071793315
LK hemonc.mhmedical.com/content.aspx?aid=1145758860
RD 2024/04/20
AB The  larynx  is  eloquent,  and  even  a  tiny  tumor  can  produce  dramatic  vocal  changes  that  frequently  allow  for  very  early  detection  of  disease.  The  American  Cancer  Society  estimated  that  in  2013,  there  would  be  12,260  laryngeal  cancers  and  3630  laryngeal  cancer  deaths.  This  progress  that  has  been  made  for  laryngeal  cancer  therapy  has  been  one  of  the  real  success  stories  in  head  and  neck  cancer.1  Improved  cure  rates  have  allowed  us  to  better  tailor  the  treatment  to  the  patient  and,  in  doing  so,  to  improve  quality  of  life.